SMS Pharmaceuticals Limited (SMSPHARMA) Share Price
NSE · Healthcare · Drug Manufacturers - General · ISIN INE812G01025
Key metrics
- Market Cap
- ₹3,535 Cr
- P/E Ratio
- 33.98
- EPS
- 11.11
- Book Value
- 83.91
- P/B Ratio
- 4.5
- ROE
- 12.98%
- ROCE
- 11.41%
- Debt / Equity
- 0.46
- Net Margin
- 11.5%
- Revenue Growth
- 13.3%
- Profit Growth
- 47.52%
- Dividend Yield
- 0.11%
- 52W High
- ₹447.80
- 52W Low
- ₹231.00
- Market Cap Band
- small cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Promoter Holding
- 76.58%
The full SMS Pharmaceuticals Limited analysis
Create a free account to open the complete SMSPHARMA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.